Needham analyst David Saxon maintains RxSight (NASDAQ:RXST) with a Buy and raises the price target from $19 to $22.
Don’t Miss These 3 Consumer Stocks With Over 3% Dividend Yields From Wall Street’s Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
